Impact of ixekizumab on psoriasis itch severity and other psoriasis symptoms: Results from 3 phase III psoriasis clinical trials.

Abstract

BACKGROUND Itch is a prevalent symptom of psoriasis that impacts quality of life. OBJECTIVE We sought to describe improvements in itch severity, skin pain, and bothersomeness of skin appearance caused by psoriasis among patients who received ixekizumab, etanercept, or placebo in three 12-week, phase III clinical trials (UNCOVER-1, -2, and -3). METHODS… (More)
DOI: 10.1016/j.jaad.2016.07.034

Topics

  • Presentations referencing similar topics